NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-144-1996-0-EP-03 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES EP National Stage 97937243.0 Abandoned
NCI E-144-1996-0-CH-08 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES CH EP 97937243.0 Abandoned
NCI E-144-1996-0-GB-05 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES GB EP 97937243.0 Abandoned
NIBIB E-235-1995-0-AU-04 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT AU National Stage 42416/97 Abandoned
NIBIB E-235-1995-0-PCT-02 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT PCT PCT PCT/US1997/015270 Expired
NCI E-144-1996-0-PCT-02 NOVEL VECTOR FOR POLYNUCLEOTIDE VACCINES PCT PCT PCT/US1997/014306 Expired
NCI E-209-1997-0-US-01 DELAYED PROGRESSION TO AIDS BY A MISSENSE ALLELE OF THE CCR2 GENE US 60/055,659 Abandoned
NIBIB E-235-1995-0-JP-06 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT JP National Stage 10-510126 Abandoned
NIBIB E-235-1995-0-CA-05 SPATIAL AND TEMPORAL CONTROL OF GENE EXPRESSION USING A HEAT SHOCK PROTEIN PROMOTER IN COMBINATION WITH LOCAL HEAT CA National Stage 2263706 Abandoned
NCI E-128-1992-1-US-02 SPECIFIC TOLERANCE IN TRANSPLANTATION US CON 08/910,287 6306651 Expired PDF
NIEHS E-298-1999-0-US-02 Dihydroxy-oxy-eicosadienoates US ORD 08/909,523 5955496 Expired PDF
NCI E-128-1992-0-AU-05 SPECIFIC TOLERANCE IN TRANSPLANTATION AU National Stage 34148/97 Abandoned
NIDDK E-072-1990-1-US-04 Nitrogen containing cyclohetero cycloalklyaminoaryl derivatives for CNS-disorders US DIV 08/910,302 5856318 Abandoned PDF
NIDDK E-241-1997-0-US-01 METHODS FOR THE LARGE SCALE PREPARATION OF DNA US 60/055,452 Abandoned
NHGRI E-242-1997-0-US-01 METHODS FOR ASSESSING GENETIC AND PHENOTYPIC MARKERS BY SIMULATANEOUS MULTICOLOR VISUALIZATION OF CHROMOGENIC DYES USING BRIGHTFIELD... US 60/055,439 Abandoned
NCI E-100-1996-0-US-03 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGS AS ANTIHERPETIC AGENTS US ORD 08/908,724 5840728 Expired PDF
NICHD E-163-1996-0-US-01 USE OF ANTISENSE OSTEOPONTIN (OPN) OLIGONUCLEOTIDES FOR PREVENTION OF CORONARY RESTENOSIS FOLLOWING ANGIOPLASTY US 60/054,967 Abandoned
NCI E-223-1992-0-US-05 SIGNAL TRANSDUCTION INHIBITOR COMPOUNDS US DIV 08/906,542 5880129 Expired PDF
NIAID E-188-1997-0-PCT-02 ENTERICALLY ADMINISTERED RECOMBINANT POXVIRUS VACCINES PCT PCT PCT/US1997/013836 Expired
NCI E-188-1996-0-CA-05 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME. CA National Stage 2263503 Expired
NCI E-188-1996-0-EP-07 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME EP National Stage 97936164.9 Expired
NCI E-188-1996-0-DE-14 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME DE EP 97936164.9 Expired
NCI E-188-1996-0-FR-15 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME FR EP 97936164.9 Expired
NCI E-188-1996-0-CH-13 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME CH EP 97936164.9 Expired
NCI E-188-1996-0-GB-16 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME GB EP 97936164.9 Expired
NCI E-188-1996-0-US-02 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME US ORD 08/906,029 6187306 Expired PDF
NCI E-188-1996-0-PCT-03 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME PCT PCT PCT/US1997/012868 Expired
NCI E-188-1996-0-AU-04 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME AU National Stage 38899/97 Abandoned
NCI E-188-1996-0-JP-06 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME JP National Stage 509732/1998 Abandoned
NCI E-143-1996-0-JP-10 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY JP National Stage 510765/98 Expired
NCI E-143-1996-0-CA-14 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY CA National Stage 2263705 Expired
NCI E-143-1996-0-IT-08 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION IT EP 97938096.1 Expired
NCI E-143-1996-0-GB-07 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION GB EP 97938096.1 Expired
NCI E-143-1996-0-EP-09 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION EP National Stage 97938096.1 Expired
NCI E-143-1996-0-LI-15 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION LI EP 97938096.1 Expired
NCI E-143-1996-0-FR-06 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION FR EP 97938096.1 Expired
NCI E-143-1996-0-DE-05 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION DE EP 97938096.1 Expired
NCI E-143-1996-0-CH-11 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION CH EP 97938096.1 Expired
NCI E-143-1996-0-SE-12 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION SE EP 97938096.1 Expired
NCI E-143-1996-0-AU-13 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION AU National Stage 40502/97 Expired
NCI E-143-1996-0-PCT-02 NOVEL DNA: LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY AND GENE EXPRESSION PCT PCT PCT/US1997/013599 Expired
NIAID E-179-1997-0-US-01 METHOD FOR INHIBITION OF HIV-1 REPLICATION US 60/054,490 Abandoned
NIDDK E-163-1991-2-US-01 A METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS US CIP 08/905,280 Abandoned
NIA E-146-1993-0-BE-31 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT BE EP 00128626.9 Expired
NCI E-175-1995-0-US-07 IN VIVO IMAGING AND OXYMETRY BY PULSED RADIOFREQUENCY PARAMAGNETIC RES ONANCECOPY BY PULSED RADIOFREQUENCY ELECTRON PARAMAGNETIC RESONANCE US CON 08/902,425 5865746 Expired PDF
NCI E-137-1996-0-PCT-02 DOUBLE-STRANDED RNA DEPENDENT PROTEIN KINASE DERIVED PEPTIDES TO PROMOTE PROLIFERATION OF CELLS AND TISSUES IN A CONTROLLED MANNER PCT PCT PCT/US1997/014350 Abandoned
NIAID E-220-1997-0-US-01 CC CHEMOKINE RECEPTOR 8 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION US 60/054,094 Abandoned
NIDDK E-133-1998-0-US-01 METHODS AND COMPOSITIONS FOR IDENTIFYING MODULATORS OF G-PROTEIN- COUPLED RECEPTORS US 60/053,935 Abandoned
NIDCR E-138-1994-0-US-02 CARTILAGE-DERIVED MORPHOGENETIC PROTEINS US National Stage 08/836,081 Abandoned
NCI E-112-1994-0-US-02 DNA ENCODING CAI RESISTANCE PROTEINS AND USES THEREOF US DIV 08/900,321 5981712 Expired PDF